Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents

Full Query

IC:A61B5/08

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2021/008737SLEEP SENSING AND MONITORING DEVICE
WO 21.01.2021
Int.Class A61B 5/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
Appl.No PCT/EP2020/054345 Applicant WITHINGS Inventor AIMON, Nicholas
The disclosure is directed to a sensing device, configured to be installed in a bedding, for monitoring a user's sleep, the device comprising: - a sensing part, for acquiring/determining a value representative of an a force or pressure and/or a value representative of a variation of a force or pressure, - a housing comprising at least a pressure transducer and an electronic processing unit, - a microphone connected to the electronic processing unit, - wherein the electronic processing unit is configured to process first and second electrical signals delivered respectively by the microphone and the pressure converter, wherein the electronic processing unit is either configured to deduce locally at least a breathing disturbance therefrom or configured to send data representative of the first and second electrical signals to a remote device.
2.WO/2021/011391SYSTEMS AND METHODS FOR MEMORY SPECIFICITY WITH VIRTUAL REALITY
WO 21.01.2021
Int.Class A61B 5/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
02Measuring pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography; Heart catheters for measuring blood pressure
Appl.No PCT/US2020/041645 Applicant THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Inventor CRASKE, Michelle, G.
Systems and methods for virtualized treatments in accordance with embodiments of the invention are illustrated. One embodiment includes a method for providing a virtualized treatment experience. The method includes steps for generating a treatment sequence includes a plurality of treatment elements, generating a virtualized environment for the generated treatment sequence, providing a plurality of treatment elements within the virtualized environment, and providing a set of one or more prompts for at least one treatment element of the plurality of treatment elements.
3.WO/2021/009215METHOD FOR DETERMINING THE FUNCTIONAL RESIDUAL CAPACITY OF A PATIENT'S LUNG AND VENTILATOR FOR CARRYING OUT THE METHOD
WO 21.01.2021
Int.Class A61B 5/091
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
091Measuring volume of inspired or expired gases, e.g. to determine lung capacity
Appl.No PCT/EP2020/069983 Applicant HAMILTON MEDICAL AG Inventor LAUBSCHER, Thomas
The present invention relates to a method for determining the functional residual capacity (FRC) of a patient's lung, comprising the following steps: - supplying a first inspiratory breathing gas having a first proportion of a metabolically inert gas, - supplying a second inspiratory breathing gas having a second proportion of the metabolically inert gas, - determining any arising volume difference, which represents a difference in volume between a volume of inspiratory and of expiratory metabolically inert gas for a determination period, - determining the functional residual capacity (FRC) taking into account the volume difference and a proportion difference between a first proportion quantity and a second proportion quantity, which represent the first proportion and the second proportion of the metabolically inert gas, respectively. According to the invention, the method comprises the following further steps: - determining a base difference (74), which represents a difference between a tidal volume of inspiratory metabolically inert gas and of expiratory metabolically inert gas, and wherein the functional residual capacity (FRC) is determined on the basis of a corrected volume difference and the proportion difference, the corrected volume difference being calculated by taking into account the base difference when determining the volume difference.
4.WO/2021/011748ESOPHAGEAL PRESSURE CLINICAL DECISION SUPPORT SYSTEM
WO 21.01.2021
Int.Class A61B 5/03
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
03Measuring fluid pressure within the body other than blood pressure, e.g. cerebral pressure
Appl.No PCT/US2020/042287 Applicant CONVERGENT ENGINEERING, INC. Inventor EULIANO, II, Neil Russell
A novel clinical decision support system (CDS) helps the clinician setup, maintain, and interpret aesophageal pressure measurement. The esophageal pressure CDS (Pes CDS) would remind the clinician to do an occlusion test whenever the balloon is first inserted or changes dramatically. It could monitor the occlusion test and provide feedback on the performance and success of the occlusion test. Changes in the patient or monitored data can be tracked by looking for changes in the balloon baseline pressure, changes in the amplitude of the pressure waveform, or changes in the pattern of the Pes waveform. Having information from the ventilator will further increase the ability of the system to determine when Pes is changing unexpectedly.
5.WO/2021/010150RESPIRATORY FUNCTION TESTING DEVICE, DATA PROCESSING METHOD, AND RESPIRATORY FUNCTION TESTING SYSTEM
WO 21.01.2021
Int.Class A61B 5/091
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
091Measuring volume of inspired or expired gases, e.g. to determine lung capacity
Appl.No PCT/JP2020/025519 Applicant CHEST M.I., INCORPORATED Inventor HISAHARA, Satoru
This respiratory function testing device processes additional data that indicates a new measurement result of a respiratory function of a subject on the basis of past data from which a spirogram can be derived and that indicates a result of measurement of the respiratory function performed in the past, the respiratory function testing device comprising: a storage unit that stores, as past data, data which indicates a measurement result in a case in which the respiratory function is normal and data which indicates a measurement result in a case in which the respiratory function is abnormal; and a control unit that determines at least one of correlations of the additional data and the past data.
6.WO/2021/011815ULTRAFAST TRACER IMAGING FOR POSITRON EMISSION TOMOGRAPHY
WO 21.01.2021
Int.Class A61B 6/03
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
6Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
02Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
03Computerised tomographs
Appl.No PCT/US2020/042401 Applicant THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Inventor ZHANG, Xuezhu
The disclosed embodiments relate to a system that performs ultra-fast tracer imaging on a subject using positron emission tomography. During operation, the system performs a high-temporal-resolution, total-body dynamic PET scan on the subject as an intravenously injected radioactive tracer propagates through the vascular system of the subject to produce PET projection data. Next, the system applies an image reconstruction technique to the PET projection data to produce subsecond temporal frames, which illustrate the dynamic propagation of the radioactive tracer through the vascular system of the subject. Finally, the system outputs the temporal frames through a display device.
7.WO/2021/005441A VITAL SIGN MEASUREMENT SYSTEM
WO 14.01.2021
Int.Class A61B 5/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
02Measuring pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography; Heart catheters for measuring blood pressure
Appl.No PCT/IB2020/055948 Applicant RAJA, K N Vijai Shankar Inventor RAJA, K N Vijai Shankar
A vital sign measurement device comprises main unit (1), a probe unit (2), a vital sign sensor (9) and a battery (10). The main unit (1) includes a microcontroller (3), a remote transceiver element (4) capable of transmitting and receiving data, a connecting port (5), and a memory unit (6). The probe unit (2) includes a digital probe identifier (7), and a connector element (8) electronically connected to each other. The vital sign sensor (9) is: (a) included in the main unit (1) and operatively connected to and controllable by the microcontroller (3), or; (b) included in the probe unit (2), and is capable of being operatively connected to and controllable by the micro controller (3) when the connecting port (5) and the connector element (8) are connected, and; the battery (10) is either external and connectible to main unit (1) or included in main unit (1), and the battery (10)capable of powering the main unit (1) and the probe unit (2).
8.10888283COVID-19 symptoms alert machine (CSAM) scanners
US 12.01.2021
Int.Class A61B 5/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
Appl.No 16917896 Applicant Boonsieng Benjauthrit Inventor Boonsieng Benjauthrit

A COVID-19 Symptoms Alert Machine (CSAM) scanner, or apparatus, is described herein. This apparatus employs Artificial Intelligent (AI) technology in combination with the latest mobile device technology (viz. smart phone/smart watch) to quickly help track down people who have COVID-19 symptoms anywhere and anytime, isolate them, and professionally handle them, not allowing SARS-CoV-2 virus to spread. CSAM automatically measures body temperature and assesses lung conditions such as pulmonary fibrosis and B-lines (for asymptomatic people), and other current health vital information (CHVI), furnished by the participant, such as fever, sore throat, headache, and body ache to generate an alert signal when COVID-19 symptoms are found significant and to send it out to a COVID-19 control center. The alerted participant is then immediately required to go to the COVID-19 control center or be picked up by a special COVID-19 emergency vehicle for isolation and further evaluation and testing. If the testing turns out to be COVID-19 positive, the participant will be quarantined and treated appropriately according to COVID-19 protocol until he/she is tested COVID-19 negative. In the meantime, people who have been in close physical contact with this participant will be alerted and requested to be immediately checked for COVID-19 symptoms. If anyone is found to have COVID-19 symptoms, then he/she must go through the same protocol. The process is repeated until all people in the cluster are tested COVID-19 negative. This will ensure that SARS-CoV-2 virus for this cluster has been completely eliminated. A rapid deployment of this type of apparatus throughout communities where people tend to congregate such as superstores, supermarkets, and any other establishments, small or large, can help to contain the rapid spread of the disease, as well as to give more confidence to the general public. People, who pass through this apparatus without an alert signal, should feel more confident in carrying out their activities, though social distancing and other COVID-19 precautionary requirements should still be maintained. The concept can be further expanded to cover shopping malls, concert halls, sports arenas, and any other large events including highways and freeways with the help of mobile phone technologies, transponders, and other mobile devices. By working on the 0.6% (around 2 million infected people in the US as of June 2020) quickly and effectively, instead of on the 99.4% (330 million, the remaining population) by locking people at home and closing down all businesses and activities; we can save a significant amount of money and hassles. (A long lockdown can also lead to a collapse of our economy and can consequently lead to a worldwide calamity.) In this way the 99.4% will not be burdened with the virus problem and can live normally without having to take any test. It is probably the only effective approach in solving the COVID-19 problem at the moment because vaccines and known COVID-19 cures are not yet available. Even if SARS-CoV-2 vaccines are available presently, they may not be practical to implement economically and operationally in time to contain the virus worldwide due to the massive amount of people (viz. over 7 billion).

9.WO/2021/002777ADAPTER FOR MEDICAL SPECTROMETER AND METHOD FOR PRODUCING SAME
WO 07.01.2021
Int.Class A61M 16/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
16Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
08Bellows; Connecting tubes
Appl.No PCT/RU2020/050026 Applicant OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU FIRMA "TRITON ELECTRONICS" Inventor CHISTIAKOV, Aleksei Vladimirovich
The proposed invention relates to the field of medical technology, and in particular to adapters for use as part of an infrared medical spectrometer. An adapter is generally a cuvette through which air exhaled by a patient passes and which is provided with windows for the passage of an infrared or light beam. An adapter window for a medical spectrometer for analyzing exhaled air in which air flows through a through-channel in the adapter with a window, disposed on mutually opposing sides of the channel such that the spectrometer beam can be directed through the window and the channel, is characterized in that the window is substantially transparent to electromagnetic radiation in the visible and/or infrared bands, a section of a profile of a side surface includes a step, and a bevel is provided where the side surface transitions to the base.
10.20210000385SYSTEMS, METHODS AND APPARATUSES FOR MONITORING HYPOXIC EVENTS
US 07.01.2021
Int.Class A61B 5/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
Appl.No 16997399 Applicant HALARE, INC. Inventor Anthony C. Warren

A portable smart device for monitoring hypoxia in a user over a period of time. The portable smart device configured to analyze the heart rate signal of the user to determine at least one of an interbeat interval (IBI) or an amplitude or a heart rate variability (HRV) of the heart rate signal, determine from the at least one of the IBI or the amplitude or the HRV, and without computing oxygen saturation in the blood, an occurrence of hypoxia over a period of time in the monitoring session, determine a length of the occurrence and an intensity of the occurrence of the hypoxia based on a change in the IBI or the amplitude or the HRV over a time period.